Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients. 1998

Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
Aichi Clinic, Toyohashi, Japan.

Various muscle symptoms are well recognized among patients on maintenance hemodialysis. Carnitine deficiency may be an important factor of dialysis-associated muscle symptoms, whereas high-dose L-carnitine supplementation may result in unphysiologically high plasma levels of carnitine and carnitine esters. We studied the effect of low-dose L-carnitine treatment (500 mg/d) on muscle symptoms, plasma carnitine fractions, and lipid profiles in 30 periodically dialyzed patients with muscular weakness, fatigue, or cramps/aches. After 12 weeks of L-carnitine treatment, about two-thirds of patients had at least some improvement in muscular symptoms, whereas carnitine fractions were normal or slightly above normal ranges, but lipid profiles showed no demonstrable changes. This study also showed the correlation between plasma-free carnitine deficiency and months on dialysis. These results suggest that prolonged low-dose L-carnitine treatment can improve dialysis-associated muscle symptoms by restoring carnitine tissue levels and washing out acyl moieties.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
January 2000, American journal of nephrology,
Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
March 1999, Kidney international. Supplement,
Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
August 2007, Calcified tissue international,
Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
November 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
August 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
November 1989, Kidney international. Supplement,
Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
February 1998, Acta paediatrica Japonica : Overseas edition,
Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
January 2006, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
January 2005, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
Y Sakurauchi, and Y Matsumoto, and T Shinzato, and I Takai, and Y Nakamura, and M Sato, and S Nakai, and M Miwa, and H Morita, and T Miwa, and I Amano, and K Maeda
October 1983, The American journal of clinical nutrition,
Copied contents to your clipboard!